Powered by LawFuel – January 23, 2020 – DLA Piper announced today that Christopher Mikson has joined the firm’s Litigation practice as a partner in Philadelphia and Washington, DC.
Mikson, who is also a medical doctor and registered patent attorney, is an accomplished litigator who focuses on Food and Drug Administration regulatory matters; complex intellectual property, commercial and product liability litigation; and transactional due diligence and counseling in the healthcare and life sciences industries.
“Chris’s unique training as a physician and lawyer makes him an invaluable addition to our growing life sciences practice,” said Loren Brown, global and US co-chair of DLA Piper’s Litigation practice. “He will greatly enhance both our regulatory and litigation capabilities in this key sector, and we are confident that our clients will value his advice and counsel immediately.”
“Chris is a great fit for our platform, and he brings a skillset that adds depth to our capabilities in a number of areas, including FDA regulatory, product liability and intellectual property matters,” said Jeff Lehrer, managing partner of the firm’s Washington, DC, office. “We are thrilled to welcome him on board.”
Mikson, who joins from Mayer Brown, received his J.D. from Rutgers Law School and his B.A. from Rutgers College. He completed the Post-Baccalaureate Premedical Program at the University of Pennsylvania and received his M.D. from Jefferson Medical College.
Recent Posts on LawFuel
- Google Goes for Big Law’s Jugular: Inside Gemini Enterprise for Legal
- From Phone-Hacking Hero to Courtroom Zero – ‘Golden Boy’ Lawyer’s Reputation Tattered By Prince Harry Defeat
- Listed Legal Disrupter Completes Second Major Law Firm Acquisition
- Kirkland’s $500 Million AI Bet Isn’t About Speed. It’s About Killing the Billable HourKirkland & Ellis, the first law firm in history to break $10 billion in revenue, is putting half a billion dollars of its own money into a proprietary AI platform. That’s a big bold move (what else would you expect from Kirklands?) which is not to keep up with Harvey or Legora, or to shave a few hours off due diligence. It’s something far more valuable. The plan is to bottle the firm’s “collective intelligence” and put it in every lawyer’s hands and, in the process, lean hard into the long-predicted death of the billable hour. Log in to read –
- Private Equity Eyes $700m WSHB Deal in Major Test for Big Law’s Ownership Rules
- What Will Clients Still Pay Lawyers For When AI Can Do The Work?
- KPMG Crisis – KPMG General Counsel & HR Chief Exit Firm Days Before Scandal Hearing
- BigLaw’s Private Equity Moment -The Next Deal Won’t Be Paul Weiss
- Second Office Romance Report Deepens Wachtell’s Extraordinary Week
